The Wall Street Transcript has published its exclusive interview with Daniel Yazbeck, the Founder and CEO of MyDx, Inc. (OTCMKTS:MYDX).
“TWST: How would they use the data? I am assuming it involves the evaluation of drugs and how they are working in patients?
Mr. Yazbeck: We have over 2,000 active hardware and device users. They tested their cannabis flowers and have associated it with a feeling. For example, we may know this cannabis flower had 18% THC, 2% CBD, and this much CBN and these other terpenes. We know that this mix helped them relieve this.”
For a free report and the other top investment highlights from the in depth interview with Daniel Yazbeck, the Founder and CEO of MyDx, Inc. (OTCMKTS:MYDX), visit TWST.com.
# # #
NOTE TO INVESTORS AND FINANCIAL NEWS EDITORS: Daniel Yazbeck, the Founder and CEO of MyDx, Inc. (OTCMKTS:MYDX) is available for interviews. Contact MyDx at http://ir.cdxlife.com/.
– See more at https://www.twst.com/report/medical-devices-10/